M. Luque-Tévar

505 total citations
20 papers, 299 citations indexed

About

M. Luque-Tévar is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, M. Luque-Tévar has authored 20 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in M. Luque-Tévar's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (3 papers). M. Luque-Tévar is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (3 papers). M. Luque-Tévar collaborates with scholars based in Spain, United Kingdom and United States. M. Luque-Tévar's co-authors include C. López-Pedrera, Nuria Barbarroja, C. Pérez‐Sánchez, Eduardo Collantes‐Estévez, Alejandro Escudero‐Contreras, I. Arias de la Rosa, M. Á. Aguirre, Marta Casado, Paloma Martı́n-Sanz and Carme Cucarella and has published in prestigious journals such as International Journal of Molecular Sciences, Arteriosclerosis Thrombosis and Vascular Biology and Frontiers in Immunology.

In The Last Decade

M. Luque-Tévar

18 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Luque-Tévar Spain	13	125	114	110	43	43	20	299
Yiming Shi China	12	141 1.1×	178 1.6×	88 0.8×	45 1.0×	46 1.1×	23	406
Y. Zhang China	11	135 1.1×	115 1.0×	168 1.5×	67 1.6×	31 0.7×	24	401
Linshuai Xu China	11	115 0.9×	164 1.4×	63 0.6×	43 1.0×	58 1.3×	16	339
Changhao Xie China	9	87 0.7×	89 0.8×	103 0.9×	17 0.4×	27 0.6×	38	269
Jinglan Ma China	5	74 0.6×	147 1.3×	127 1.2×	44 1.0×	62 1.4×	6	340
Yehua Jin China	10	125 1.0×	135 1.2×	48 0.4×	46 1.1×	72 1.7×	15	309
Fanru Meng China	7	98 0.8×	195 1.7×	60 0.5×	20 0.5×	171 4.0×	8	364
Zihao Li China	8	127 1.0×	258 2.3×	63 0.6×	10 0.2×	52 1.2×	14	407
Ani Shahbazian United States	9	154 1.2×	100 0.9×	47 0.4×	15 0.3×	14 0.3×	17	356
Chiari Kojima Japan	13	63 0.5×	57 0.5×	100 0.9×	54 1.3×	14 0.3×	25	394

Countries citing papers authored by M. Luque-Tévar

Since Specialization

Citations

This map shows the geographic impact of M. Luque-Tévar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Luque-Tévar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Luque-Tévar more than expected).

Fields of papers citing papers by M. Luque-Tévar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Luque-Tévar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Luque-Tévar. The network helps show where M. Luque-Tévar may publish in the future.

Co-authorship network of co-authors of M. Luque-Tévar

This figure shows the co-authorship network connecting the top 25 collaborators of M. Luque-Tévar. A scholar is included among the top collaborators of M. Luque-Tévar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Luque-Tévar. M. Luque-Tévar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luque-Tévar, M., Carme Cucarella, Agustín Lahoz, et al.. (2024). Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice. Liver International. 44(9). 2409–2423.

López-Pedrera, C., Alejandro Ibáñez‐Costa, M. Luque-Tévar, et al.. (2023). The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis. Journal of Thrombosis and Haemostasis. 21(10). 2894–2907. 7 indexed citations

Luque-Tévar, M., et al.. (2023). Advances in Understanding the Role of NRF2 in Liver Pathophysiology and Its Relationship with Hepatic-Specific Cyclooxygenase-2 Expression. Antioxidants. 12(8). 1491–1491. 22 indexed citations

Luque-Tévar, M., Carme Cucarella, Lisardo Boscá, et al.. (2022). COX-2 Expression in Hepatocytes Improves Mitochondrial Function after Hepatic Ischemia-Reperfusion Injury. Antioxidants. 11(9). 1724–1724. 19 indexed citations

Rosa, I. Arias de la, C. Pérez‐Sánchez, Clementina López‐Medina, et al.. (2022). The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast. Journal of Internal Medicine. 291(5). 676–693. 19 indexed citations

López-Pedrera, C., José M. Villalba, M. Luque-Tévar, et al.. (2021). Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases. Antioxidants. 10(4). 600–600. 22 indexed citations

Rosa, I. Arias de la, Alejandro Escudero‐Contreras, M. Ruiz-Ponce, et al.. (2021). Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs. Frontiers in Immunology. 12. 744022–744022. 7 indexed citations

Rosa, I. Arias de la, C. Pérez‐Sánchez, Clementina López‐Medina, et al.. (2021). POS1001 CLINICAL AND SURROGATE CARDIOVASCULAR RISK ASSESSMENT AND ITS RELATIONSHIP WITH PSORIATIC ARTHRITIS PATHOGENESIS. Annals of the Rheumatic Diseases. 80. 769–769.

Pérez‐Sánchez, C., M. C. Ábalos‐Aguilera, M. Luque-Tévar, et al.. (2021). POS0394 NAD+ BOOSTERS REESTABLISH THE ALTERED NAD+ METABOLISM OF LEUKOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS IMPROVING THEIR OXIDATIVE, APOPTOTIC AND INFLAMMATORY STATUS. Annals of the Rheumatic Diseases. 80. 426–426. 1 indexed citations

10.

Pérez‐Sánchez, C., M. Luque-Tévar, M. C. Ábalos‐Aguilera, et al.. (2021). Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Arteriosclerosis Thrombosis and Vascular Biology. 41(9). 2417–2430. 40 indexed citations

11.

López-Pedrera, C., Nuria Barbarroja, M. Luque-Tévar, et al.. (2020). Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis. International Journal of Molecular Sciences. 21(23). 9067–9067. 25 indexed citations

12.

Rosa, I. Arias de la, Pilar Font, Alejandro Escudero‐Contreras, et al.. (2020). Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis. Therapeutic Advances in Chronic Disease. 11. 1754256843–1754256843. 17 indexed citations

13.

Aguirre, M. Á., M. Luque-Tévar, M. C. Ábalos‐Aguilera, et al.. (2020). Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 865–877. 19 indexed citations

14.

López-Pedrera, C., Nuria Barbarroja, M. Luque-Tévar, et al.. (2020). Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders. International Journal of Molecular Sciences. 21(6). 2012–2012. 19 indexed citations

15.

Rosa, I. Arias de la, M. Luque-Tévar, Alejandro Ibáñez‐Costa, et al.. (2020). Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission. Pediatric Rheumatology. 18(1). 59–59. 15 indexed citations

16.

Rosa, I. Arias de la, M. C. Ábalos‐Aguilera, D. Ruiz, et al.. (2020). THU0381 MANAGEMENT OF CARDIOVASCULAR COMORBIDITY IN PSORIATIC ARTHRITIS IN THE ROUTINE CLINICAL PRACTICE: A COMPARATIVE STUDY OF METHOTREXATE OR APREMILAST AS MONOTHERAPY AND COMBINED. Annals of the Rheumatic Diseases. 79. 424–425. 1 indexed citations

17.

Pérez‐Sánchez, C., Irene Cecchi, Nuria Barbarroja, et al.. (2019). Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion. Journal of Cellular and Molecular Medicine. 23(9). 6308–6318. 15 indexed citations

18.

Ruiz‐Limón, Patricia, R. Ortega Castro, Nuria Barbarroja, et al.. (2019). Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis. Frontiers in Immunology. 10. 1111–1111. 19 indexed citations

19.

Rosa, I. Arias de la, C. Pérez‐Sánchez, M. Luque-Tévar, et al.. (2019). SAT0036 IMPACT OF RHEUMATOID ARTHRITIS IN LIVER DAMAGE. INVOLVEMENT OF ANTI-CITRULLINATED PROTEIN ANTIBODIES. Annals of the Rheumatic Diseases. 78. 1082–1082. 1 indexed citations

20.

Pérez‐Sánchez, C., I. Arias de la Rosa, M. Á. Aguirre, et al.. (2018). Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. Haematologica. 103(5). 908–918. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact